Loading
₹47.00
−2.10%BSE close, 16 Nov 2026
+47.85%
GENOMIC VALLEY BIOTECH is a small cap company in the Healthcare sector, listed on BSE under the symbol GVBL (BSE code 539206). At ₹47.00 a share, the market values the whole company at ₹14 crore.
Over the past year the share price has risen 51.6%, and it is 23.4% below its 52-week high.
Companies of a similar size in the same sector include TRANSGENE BIOTEK, LOOKS HEALTH SERVICES, VENMAX DRUGS AND PHARMACEUTICA and Global Longlife Hospital and R.
This company is listed only on BSE, so its page shows price figures only: results and shareholding on RupeeVerse come from companies’ NSE filings.
The same sector (Healthcare), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| GENOMIC VALLEY BIOTECH | ₹47.00 | ₹14 cr | n/a | n/a | n/a | +51.56% |
| TRANSGENE BIOTEK | ₹2.44 | ₹16 cr | n/a | n/a | n/a | −28.02% |
| LOOKS HEALTH SERVICES | ₹14.15 | ₹15 cr | n/a | n/a | n/a | +182.44% |
| VENMAX DRUGS AND PHARMACEUTICA | ₹12.36 | ₹14 cr | n/a | n/a | n/a | −55.60% |
| Global Longlife Hospital and R | ₹13.53 | ₹14 cr | n/a | n/a |
| −42.96% |
| STARSOURCE MULTITRADE | ₹91.75 | ₹14 cr | n/a | n/a | n/a | −22.28% |
|---|
| DESH RAKSHAK AUSHDHALAYA | ₹23.50 | ₹13 cr | n/a | n/a | n/a | −34.17% |
|---|
| Vanta Bioscience | ₹18.50 | ₹13 cr | n/a | n/a | n/a | −33.19% |
|---|
| UNJHA FORMULATIONS | ₹27.87 | ₹12 cr | n/a | n/a | n/a | +21.23% |
|---|